Literature DB >> 26285753

Vasculogenesis and Angiogenesis in VEGF Receptor-1 Deficient Mice.

Vivienne C Ho1, Guo-Hua Fong.   

Abstract

Vascular endothelial growth factor receptor-1 (VEGFR-1)/Flt-1 is a transmembrane tyrosine kinase receptor for VEGF-A, VEGF-B, and placental growth factor (PlGF). VEGFR-1 is an enigmatic molecule whose precise role in postnatal angiogenesis remains controversial. Although many postnatal and adult studies have been performed by manipulating VEGFR-1 ligands, including competitive binding by truncated VEGFR-1 protein, neutralization by antibodies, or specific ligand overexpression or knockout, much less is known at the level of the receptor per se, especially in vivo. Perplexingly, while VEGFR-1 negatively regulates endothelial cell differentiation during development, it has been implied in promoting angiogenesis under certain conditions in adult tissues, especially in tumors and ischemic tissues. Additionally, it is unclear how VEGFR-1 is involved in vascular maturation and maintenance of vascular quiescence in adult tissues. To facilitate further investigation, we generated a conditional knockout mouse line for VEGFR-1 and characterized angiogenesis in postnatal and adult mice, including angiogenesis in ischemic myocardium. These methods are briefly outlined in this chapter. We also discuss these findings in the context of the interplay between VEGF family members and their receptors, and summarize various mouse models in the VEGF pathway.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26285753      PMCID: PMC4544766          DOI: 10.1007/978-1-4939-2917-7_12

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  46 in total

1.  Neuropilin-2 is required in vivo for selective axon guidance responses to secreted semaphorins.

Authors:  R J Giger; J F Cloutier; A Sahay; R K Prinjha; D V Levengood; S E Moore; S Pickering; D Simmons; S Rastan; F S Walsh; A L Kolodkin; D D Ginty; M Geppert
Journal:  Neuron       Date:  2000-01       Impact factor: 17.173

2.  Synergism between vascular endothelial growth factor and placental growth factor contributes to angiogenesis and plasma extravasation in pathological conditions.

Authors:  P Carmeliet; L Moons; A Luttun; V Vincenti; V Compernolle; M De Mol; Y Wu; F Bono; L Devy; H Beck; D Scholz; T Acker; T DiPalma; M Dewerchin; A Noel; I Stalmans; A Barra; S Blacher; T VandenDriessche; A Ponten; U Eriksson; K H Plate; J M Foidart; W Schaper; D S Charnock-Jones; D J Hicklin; J M Herbert; D Collen; M G Persico
Journal:  Nat Med       Date:  2001-05       Impact factor: 53.440

3.  Arteriolar and venular patterning in retinas of mice selectively expressing VEGF isoforms.

Authors:  Ingeborg Stalmans; Yin-Shan Ng; Richard Rohan; Marcus Fruttiger; Ann Bouché; Ali Yuce; Hajime Fujisawa; Bart Hermans; Moshe Shani; Sandra Jansen; Dan Hicklin; David J Anderson; Tom Gardiner; Hans-Peter Hammes; Lieve Moons; Mieke Dewerchin; Désiré Collen; Peter Carmeliet; Patricia A D'Amore
Journal:  J Clin Invest       Date:  2002-02       Impact factor: 14.808

4.  Vascular endothelial growth factor-B-deficient mice display an atrial conduction defect.

Authors:  K Aase; G von Euler; X Li; A Pontén; P Thorén; R Cao; Y Cao; B Olofsson; S Gebre-Medhin; M Pekny; K Alitalo; C Betsholtz; U Eriksson
Journal:  Circulation       Date:  2001-07-17       Impact factor: 29.690

5.  Mice lacking the vascular endothelial growth factor-B gene (Vegfb) have smaller hearts, dysfunctional coronary vasculature, and impaired recovery from cardiac ischemia.

Authors:  D Bellomo; J P Headrick; G U Silins; C A Paterson; P S Thomas; M Gartside; A Mould; M M Cahill; I D Tonks; S M Grimmond; S Townson; C Wells; M Little; M C Cummings; N K Hayward; G F Kay
Journal:  Circ Res       Date:  2000-02-04       Impact factor: 17.367

6.  Aberrant sensory innervation of the olfactory bulb in neuropilin-2 mutant mice.

Authors:  Andreas Walz; Ivan Rodriguez; Peter Mombaerts
Journal:  J Neurosci       Date:  2002-05-15       Impact factor: 6.167

7.  Targeting of both mouse neuropilin-1 and neuropilin-2 genes severely impairs developmental yolk sac and embryonic angiogenesis.

Authors:  Seiji Takashima; Masafumi Kitakaze; Masanori Asakura; Hiroshi Asanuma; Shoji Sanada; Fumi Tashiro; Hitoshi Niwa; Jun-ichi Miyazaki Ji; Seiichi Hirota; Yukihiko Kitamura; Takashi Kitsukawa; Hajime Fujisawa; Michael Klagsbrun; Masatsugu Hori
Journal:  Proc Natl Acad Sci U S A       Date:  2002-03-12       Impact factor: 11.205

8.  Flt-1 lacking the tyrosine kinase domain is sufficient for normal development and angiogenesis in mice.

Authors:  S Hiratsuka; O Minowa; J Kuno; T Noda; M Shibuya
Journal:  Proc Natl Acad Sci U S A       Date:  1998-08-04       Impact factor: 11.205

9.  Revascularization of ischemic tissues by PlGF treatment, and inhibition of tumor angiogenesis, arthritis and atherosclerosis by anti-Flt1.

Authors:  Aernout Luttun; Marc Tjwa; Lieve Moons; Yan Wu; Anne Angelillo-Scherrer; Fang Liao; Janice A Nagy; Andrea Hooper; Josef Priller; Bert De Klerck; Veerle Compernolle; Evis Daci; Peter Bohlen; Mieke Dewerchin; Jean-Marc Herbert; Roy Fava; Patrick Matthys; Geert Carmeliet; Désiré Collen; Harold F Dvorak; Daniel J Hicklin; Peter Carmeliet
Journal:  Nat Med       Date:  2002-07-01       Impact factor: 53.440

10.  Insufficient VEGFA activity in yolk sac endoderm compromises haematopoietic and endothelial differentiation.

Authors:  Annette Damert; Lucile Miquerol; Marina Gertsenstein; Werner Risau; Andras Nagy
Journal:  Development       Date:  2002-04       Impact factor: 6.868

View more
  7 in total

1.  Modulating Angiogenesis by Proteomimetics of Vascular Endothelial Growth Factor.

Authors:  Sami Abdulkadir; Chunpu Li; Wei Jiang; Xue Zhao; Peng Sang; Lulu Wei; Yong Hu; Qi Li; Jianfeng Cai
Journal:  J Am Chem Soc       Date:  2021-12-30       Impact factor: 15.419

2.  The effects of bone morphogenetic protein 2 and thrombopoietin treatment on angiogenic properties of endothelial cells derived from the lung and bone marrow of young and aged, male and female mice.

Authors:  Ushashi C Dadwal; Fazal Ur Rehman Bhatti; Olatundun D Awosanya; Rohit U Nagaraj; Anthony J Perugini; Seungyup Sun; Conner R Valuch; Caio de Andrade Staut; Stephen K Mendenhall; Nikhil P Tewari; Sarah L Mostardo; Murad K Nazzal; Hanisha L Battina; Donghui Zhou; Deepa Kanagasabapathy; Rachel J Blosser; Patrick L Mulcrone; Jiliang Li; Melissa A Kacena
Journal:  FASEB J       Date:  2021-09       Impact factor: 5.834

3.  Housing Conditions and a Challenge with Lipopolysaccharide on the Day of Estrus Can Influence Gene Expression of the Corpus Luteum in Gilts.

Authors:  Arthur Nery da Silva; Luana Alves; Germana Vizzotto Osowski; Leandro Sabei; Priscila Assis Ferraz; Guilherme Pugliesi; Mariana Groke Marques; Ricardo Zanella; Adroaldo José Zanella
Journal:  Genes (Basel)       Date:  2022-04-26       Impact factor: 4.141

4.  A role for aldehyde dehydrogenase (ALDH) 2 in angiotensin II-mediated decrease in angiogenesis of coronary endothelial cells.

Authors:  Bipradas Roy; Suresh Selvaraj Palaniyandi
Journal:  Microvasc Res       Date:  2021-01-09       Impact factor: 3.514

5.  Slit2 suppresses endothelial cell proliferation and migration by inhibiting the VEGF-Notch signaling pathway.

Authors:  Guo-Jian Li; Yong Yang; Guo-Kai Yang; Jia Wan; Dao-Lei Cui; Zhen-Huan Ma; Ling-Juan Du; Gui-Min Zhang
Journal:  Mol Med Rep       Date:  2017-02-22       Impact factor: 2.952

6.  Vascular Endothelial Growth Factor B and Its Signaling.

Authors:  Nathaniel Lal; Karanjit Puri; Brian Rodrigues
Journal:  Front Cardiovasc Med       Date:  2018-04-20

Review 7.  Beyond thrombosis: the impact of tissue factor signaling in cancer.

Authors:  Dusten Unruh; Craig Horbinski
Journal:  J Hematol Oncol       Date:  2020-07-14       Impact factor: 17.388

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.